RNA processing modification mediated subtypes illustrate the distinctive features of tumor microenvironment in hepatocellular carcinoma

被引:0
|
作者
Xinhui Li
Shan Liu
Laibin Zou
Min Dai
Chaobei Zhu
机构
[1] Renmin Hospital,Department of Oncology
[2] Hubei University of Medicine,Department of Hepatobiliary and Pancreatic Surgery
[3] Huadu District People´s Hospital of Guangzhou,Department of Traditional Chinese Medicine and Allergy
[4] The Third School of Clinical Medicine,Department of Gastroenterology
[5] Southern Medical University,undefined
[6] The third affiliated hospital of Sun Yet-sen University,undefined
[7] Renmin Hospital,undefined
[8] Hubei University of Medicine,undefined
来源
Genes & Immunity | 2024年 / 25卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Multiple transcript isoforms of genes can be formed by processing and modifying the 5′ and 3′ ends of RNA. Herein, the aim of this study is to uncover the characteristics of RNA processing modification (RPM) in hepatocellular carcinoma (HCC), and to identify novel biomarkers and potential targets for treatment. Firstly, integrated bioinformatics analysis was carried out to identify risk prognostic RPM regulators (RPMRs). Then, we used these RPMRs to identify subtypes of HCC and explore differences in immune microenvironment and cellular function improvement pathways between the sub-types. Finally, we used the principal component analysis algorithms to estimate RPMscore, which were applied to 5 cohorts. Lower RPMscore among patients correlated with a declined survival rate, increased immune infiltration, and raised expression of immune checkpoints, aligning with the “immunity tidal model theory”. The RPMscore exhibited robust, which was validated in multiple datasets. Mechanistically, low RPMscore can create an immunosuppressive microenvironment in HCC by manipulating tumor-associated macrophages. Preclinically, patients with high RPMscore might benefit from immunotherapy. The RPMscore is helpful in clustering HCC patients with distinct prognosis and immunotherapy. Our RPMscore model can help clinicians to select personalized therapy for HCC patients, and RPMscore may act a part in the development of HCC.
引用
收藏
页码:132 / 148
页数:16
相关论文
共 50 条
  • [21] m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
    Liu, Fen
    Liu, Qingbin
    Li, Xianying
    Wang, Yufei
    Cao, Ruoyu
    Zhang, Shiyu
    Jiang, Shulong
    Wu, Jianlin
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [22] The role of RNA modification in hepatocellular carcinoma
    Feng, Qiang
    Wang, Dongxu
    Xue, Tianyi
    Lin, Chao
    Gao, Yongjian
    Sun, Liqun
    Jin, Ye
    Liu, Dianfeng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] Status and Development of The Tumor Microenvironment in Hepatocellular Carcinoma
    Liu Zhi-Lei
    Sun Wei
    He Fu-Chu
    Cong Xian-Ling
    Jiang Ying
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2012, 39 (05) : 416 - 422
  • [24] Current perspectives on the tumor microenvironment in hepatocellular carcinoma
    Santhakumar, Cositha
    Gane, Edward J.
    Liu, Ken
    McCaughan, Geoffrey W.
    HEPATOLOGY INTERNATIONAL, 2020, 14 (06) : 947 - 957
  • [25] Editorial: Immunometabolism and tumor microenvironment in hepatocellular carcinoma
    Zhang, Luyun
    Tao, Lianyuan
    Tian, Dean
    Li, Dongxiao
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] DECODING THE IMMUNE TUMOR MICROENVIRONMENT OF HEPATOCELLULAR CARCINOMA
    Sia, Daniela
    Torres-Martin, Miguel
    Wang, Huan
    Haber, Philipp
    Puigvehi, Marc
    Montironi, Carla
    Maeda, Miho
    Wei-Qiang, Leow
    Harrod, Elizabeth
    Taik, Patricia
    Chinburen, Jigjidsuren
    Taivanbaatar, Erdenebileg
    Chinbold, Enkhbold
    Donovan, Michael
    Thung, Swan N.
    Neely, Jaclyn
    Mazzaferro, Vincenzo
    Anderson, Jeffrey
    Roayaie, Sasan
    Schwartz, Myron E.
    Villanueva, Augusto
    Friedman, Scott L.
    Uzilov, Andrew
    Llovet, Josep M.
    HEPATOLOGY, 2019, 70 : 1133A - 1134A
  • [27] Oncogenic Signal and Tumor Microenvironment in Hepatocellular Carcinoma
    Nishida, Naoshi
    Kudo, Masatoshi
    ONCOLOGY, 2017, 93 : 160 - 164
  • [28] Recent advances in tumor microenvironment of hepatocellular carcinoma
    Nakagawa, Hayato
    CANCER SCIENCE, 2024, 115 : 1661 - 1661
  • [29] Current perspectives on the tumor microenvironment in hepatocellular carcinoma
    Cositha Santhakumar
    Edward J. Gane
    Ken Liu
    Geoffrey W. McCaughan
    Hepatology International, 2020, 14 : 947 - 957
  • [30] Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma
    Xiao, Jingjing
    Liu, Zhenhua
    Wang, Jinlong
    Zhang, Shuaimin
    Zhang, Yi
    FRONTIERS IN ONCOLOGY, 2022, 12